Mirum Pharmaceuticals (MIRM) EBT (2019 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly EBT came in at -$789.7 million in Q1 2026, down 5686.05% year-on-year from $14.1 million in Q1 2025, and down 15811.34% quarter-over-quarter from -$5.0 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) EBT (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' EBT history runs 8 years deep, the most recent figure standing at -$789.7 million for Q1 2026.
- On a quarterly basis, EBT fell 5686.05% year-over-year to -$789.7 million in Q1 2026; TTM through Mar 2026 was -$797.5 million, a 950.6% decrease from a year earlier, with the FY2025 full-year figure at -$21.4 million, up 75.35% from the prior year.
- EBT slipped to -$789.7 million in Q1 2026 per MIRM's latest filing, from -$5.0 million in the prior quarter.
- Across five years, EBT topped out at $2.6 million in Q3 2025 and bottomed at -$789.7 million in Q1 2026.
- The 5-year median for EBT is -$24.7 million (2024), against an average of -$70.7 million.
- Across the five-year window, EBT surged 119.03% in 2025 and slumped 5686.05% in 2026, its largest moves.
- Year by year, EBT stood at -$36.3 million in 2022, then climbed by 2.36% to -$35.4 million in 2023, then soared by 31.24% to -$24.4 million in 2024, then surged by 79.63% to -$5.0 million in 2025, then tumbled by 15811.34% to -$789.7 million in 2026.
- Per Business Quant, the three latest MIRM EBT figures stand at -$789.7 million (Q1 2026), -$5.0 million (Q4 2025), and $2.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -789.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -789.68 Mn |
| Dec 31, 2025 | -4.96 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | -5.46 Mn |
| Mar 31, 2025 | -13.65 Mn |
| Dec 31, 2024 | -24.37 Mn |
| Sep 30, 2024 | -13.89 Mn |
| Jun 30, 2024 | -24.00 Mn |
| Mar 31, 2024 | -24.66 Mn |
| Dec 31, 2023 | -35.43 Mn |
| Sep 30, 2023 | -23.34 Mn |
| Jun 30, 2023 | -73.72 Mn |
| Mar 31, 2023 | -29.93 Mn |
| Dec 31, 2022 | -36.29 Mn |
| Sep 30, 2022 | -35.69 Mn |
| Jun 30, 2022 | -33.49 Mn |
| Mar 31, 2022 | -36.60 Mn |
| Dec 31, 2021 | 57.29 Mn |
| Sep 30, 2021 | -47.10 Mn |
| Jun 30, 2021 | -43.88 Mn |